Indication
Locally Recurrent OCSCC
1 clinical trial
2 products
Clinical trial
A Phase 2 Study to Evaluate the Efficacy of the Combination of Cemiplimab and Cetuximab Prior to Salvage Surgery in Patients With Locally Recurrent (Stage 3-5) OCSCCStatus: Not yet recruiting, Estimated PCD: 2025-05-15
Product
CemiplimabProduct
Cetuximab